In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is focusing on strategically advancing its portfolio of clinical trials across autoimmune ... later in 2025 for hereditary angioedema and olezarsen for ...

Testing confirmed that Powers did not have an autoimmune rheumatic disease ... Ph.D., at WVU Medicine Pediatric and Adult Allergy/Immunology, for possible angioedema, or swelling in the deeper layers ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

Q. In 2009, Allergan was running a long-term study on silicone breast implants. I had always wanted a more feminine body like the girls in the magazines, so I joined and got implants. They never ...

At JP Morgan last month, pharmaphorum caught up with Paul Hastings, the CEO of Nkarta, to talk about NK cells and autoimmune diseases.

Researchers present cases of patients who may have developed autoimmune disorders after receiving COVID-19 vaccines. At the time of writing, it has been nearly 2 years since the World Health ...

An individual with immunoglobulin G4-related disease (IgG4-RD) and autoimmune hepatitis (AIH) was successfully treated with high-dose glucocorticoids, according to a letter to the editor of the ...

At only 27 years old, Daniela Powers felt like she was dying. What began as unexplained rashes exploded into a debilitating ...

Klinefelter syndrome is a genetic condition that affects only males. Here's what you should know about the causes, symptoms, and treatment options for the condition. Klinefelter syndrome is a genetic ...

A panelist discusses how neurokinin-targeted therapies can be strategically combined with existing treatments to address multiple vasomotor symptoms (VMS) while highlighting their positive impact on ...